Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 356 for “"HCT116"”.
-
Effect of triazole-based compounds on pre-mrna splicing in hct116 cells /
… pre-mRNA splicing of tumour-associated genes in HCT116 cells, including the evaluation of the effects of the triazole-based compounds on the viability of cells. Also, to compare tumour-associated mRNA isoform formation under normoxia and hypoxia, and to evaluate the effects of selected …
-
The response of chemoresistant human colorectal cancer cells HCT116 to cytotoxic treatment /
… pathways for the response of human CRC cells HCT116 and chemoresistant sublines HCT116/FU (generated by cell cultivation with 5-fluorouracil, hereafter 5-FU), HCT116/OXA (generated by cell cultivation with oxaliplatin, hereafter OxaPt) to cytotoxic treatment was investigated. In monolayer cell …
-
Sacharomyces cerevisiae L-A-1 viruso kapsidžių transfekcinio pajėgumo žinduolių ląstelėse HCT116 vertinimas /
… the viability of the human cancer cell line HCT116. The highest levels of L-A-1 virus VLPs were found to be produced in the BY4741 ΔPOR1 GagWT strain, and the most efficient VLPs purification method was using PEG4000. Purification method using PEG4000 is 10 times more efficient than …
-
Chemoterapiniams vaistams atsparių kolorektalinio vėžio ląstelių HCT116 atsako į citotoksinį poveikį molekuliniai aspektai /
… pathways for the response of human CRC cells HCT116 and chemoresistant sublines HCT116/FU (generated by cell cultivation with 5-fluorouracil, hereafter 5-FU), HCT116/OXA (generated by cell cultivation with oxaliplatin, hereafter OxaPt) to cytotoxic treatment was investigated. In monolayer cell …
-
Knockout of DROSHA Increases the Sensitivity of HCT116 Cells to Apoptosis in Response to Actinomycin-D Treatment
… (ACT-D) was examined in a genetically modified HCT116 colon cancer cell line with a deletion in the gene encoding a critical miRNA processing enzyme called DROSHA. We found that the DROSHA-null subline was more susceptible than the parental cells expressing wild-type DROSHA to apoptosis induced …
-
Regulation and function of the novel candidate tumor suppressor Gene Dlec1 in the HCT116 colorectal cancer cell line
… and function of DLEC1 in colorectal cancer. In HCT116 cell line, the PI3K-AKT-mTOR, JNK-SAPK, Ras-Raf-MEK-ERK pathways are constitutively activated. To study the possible mechanism of regulation of DLEC1 by these signaling pathways, RT-PCR was performed to screen for potential drugs that could …
-
A multiplex comparative proteomic analysis of hypoxia influence in the presence and absence of p53 in HCT116 Cells
… in cultured human colorectal cancer cells, HCT116, subjected to hypoxic condition using isobaric tags (iTRAQ) and mass spectrometry. Using p53 knockout (KO) cells, we also examine the elusive relationship between hypoxia and p53 by analyzing their protein profiles. At 95% C.I., a total of …
-
INVESTIGATING Β-1,4-GALACTOSYLTRANSFERASE V KNOCKOUT IN HCT116 CELLS VIA CRISPR-CAS9: INSIGHTS INTO CELL PROLIFERATION AND CANCER PROGRESSION
… CRISPR-Cas9-mediated knockout of GALT-V in HCT116 cells using high and low efficiency single guide RNAs (sgRNAs). GALT-V protein levels were reduced by 3.25 fold in the high-efficiency KO and 1.27 fold in the low-efficiency KO compared to untreated placebo cells as measured by ELISA. At the …
-
Oksaliplatinai atsparių HCT116 storosios žarnos vėžinių ląstelių sublinijų, pasižyminčių sumažinta miR-23b ir miR-27b raiška, išvedimas, panaudojant CRISPR-Cas9 sistemą /
Generation of Oxaliplatin Resistant HCT116 Colorectal Cancer Cell Sublines, with Reduced miR-23b and miR-27b miRNA Expression, Using CRISPR-Cas9 System Clinical and in vitro experiments show that Oxa/HCT116 colorectal cancer cells resistant to oxaliplatin chemotherapy have an upregulated expression …
-
APM2 is a novel mediator of cisplatin resistance in a variety of cancer cell types in vitro and in xenograft models of cancer
… obstacle facing cancer patients. The untreated HCT116 cell line was subcloned and each clone was assessed for its response to several drugs and X-radiation. One clone HCT116-K was resistant to cisplatin/etoposide/topotecan but sensitive to XR while another HCT116-2 was sensitive to cisplatin but …
-
Evaluating the anti-proliferative effects of exercise on colorectal cancer cell lines HCT116 and HT29 through treatment of myokines produced ffrom C2C12 cells subjected to electric pulse stimulation
… by C2C12 cells in colorectal cancer cell lines: HCT116 and HT29, by looking at changes in protein expression through western blot analysis and protein arrays. METHODS: C2C12 cells were grown in cell culture plates and differentiated into myotubules. Myotubules were subjected to Electronic Pulse …
-
Analysis of the glutamine dependent transaminases as possible therapeutic targets in colon cancer cells
… growth and metabolism in the colon cancer cells HCT116 and RKO that rely on glutamine’s nitrogen. The non-cancerous HEK293 cells were tested in parallel to understand the specific metabolic settings and differences in glutamine-independent proliferation. A proteome analysis via liquid …
-
Auswirkungen einer aktivierenden PIK3CA-Mutation auf die Signaltransduktion von FasL und TRAIL in kolorektalen Karzinomzellen
… Variante der kolorektalen Karzinomzelllinie HCT116 untersucht. Eine aktivierende Mutation des PIK3CA-Gens protektiert diese Zellen aufgrund der konstitutiven Aktivierung des onkogenen PI3K/Akt-Signalweges gegenüber Todesrezeptor-vermittelter Apoptose. Durch Vergleich isogener Zelllinien, …
-
A Study into the Effects of Platelets, Platelet Releasate and Aspirin on Colorectal Cancer Cells
… healthy controls and CRC patients. HCT15 and HCT116 CRC cells were able to activate platelets from controls or patients in a dose dependent manner but aspirin did not have an effect on activation. There was also no difference in activation between controls or patients. The binding of platelets …
-
Estudo in vitro da atividade antitumoral do ditelureto de difenila e mecanismos de ação relacionados em células tumorais
… deste estudo foi avaliar os efeitos do DTDF em HCT116 (CCR) em comparação a células não tumorais MRC5 (fibroblasto humano), determinando possíveis mecanismos de ação que estão envolvidos no processo citotóxico. Os resultados indicaram que as células HCT116 são mais sensíveis aos efeitos …
-
Παθογένεση του κολο-ορθικού καρκίνου: ο ρόλος των αναστολέων της κυκλοοξυγενάσης, του συστήματος ουβικουϊτίνης-πρωτεασώματος και πειραματικές εφαρμογές
… and methods: Human colorectal cancer cells lines HCT116, HT-29 and CaCo2 growing in RPMI1640 medium in the presence or absence of ASA and bortezomib were used in the experiments. MTT assay, trypan blue exclusion and DNA fragmentation were the assays used for the measurement of cell proliferation …
-
Low levels of methylation are targeted to aberrantly methylated CGIs in human colorectal cancer cells
… this, I used human colorectal cancer cell line (HCT116) as a model. Firstly, I have ectopically integrated representative aberrantly methylated CGIs randomly into the genome and assessed their methylation at ectopic loci. I show that integrated CGIs rarely gained methylation at ectopic locations. …
-
Luciferase Reporter CRC Cell Line for Bioluminescence Imaging in Orthotopic Tumor Model
… and most effective technique. We have generated HCT116, a human colon carcinoma cell line, and MC38, a mouse colon carcinoma cell line expressing the luciferase gene constitutively. The optimization of four different transfection reagents was done. HCT116 and MC38 cells were finally transfected …
-
Cellular Effects Nanosilver on Cancer and Non-cancer Cells: Potential Environmental and Human Health Impacts
… therapeutic. In this study, human colon cancer (HCT116) and intestinal epithelial (HIEC-6) cells were used to study nanosilver effects in cancer versus non-cancer cells. Nanosilver increased Nrf2 protein expression and disrupted the cell cycle at the G1 and G2/M phases. Hypoxia attenuated …
-
Therapeutic Drugs in Cancer
… Sorafenib and vorinostat synergized to kill HCT116 and SW480 cells. In SW480 cells, sorafenib+vorinostat toxicity correlated with CD95 activation and CD95-stimulated autophagy. Drug lethality in SW480 cells was blocked by knock down of CD95. In SW620 cells that are patient matched to SW480 …
Page 1 of 18